Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 212.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 518.00 | |
50 mg | In stock | $ 749.00 | |
100 mg | In stock | $ 1,060.00 | |
500 mg | In stock | $ 2,090.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 218.00 |
Description | VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice. |
Molecular Weight | 258.32 |
Formula | C18H14N2 |
CAS No. | 218464-59-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 16 mg/ml(61.94 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VPC-13566 218464-59-6 Endocrinology/Hormones Androgen Receptor VPC13566 VPC 13566 inhibitor inhibit